Market News AIOpen the app

TG Therapeutics is the fifth fastest-growing company in North America, thanks to its successful multiple sclerosis treatment, BRIUMVI.

MarketRead the original at barchart.com
Good for TGTX

TG Therapeutics ranked 5th on Deloitte's 2026 list, reflecting growth tied to BRIUMVI. This supports its business outlook, but the ranking looks back at 2022–2025 and gives no current sales figures.

TGTX · TG Therapeutics, Inc.

AI read · Good for TGTX

The AI's read

BRIUMVI's commercial success is the reason the company gives for its growth. That points to demand for an approved treatment. The list looks back at past growth and gives no current sales figures or company forecast, so it cannot show whether that pace continues.

Get alerts for TGTX

Follow TG Therapeutics, Inc. (TGTX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TGTX
Free on the App Store and Google Play, or on the web.